Ventas Cambio Fecha
Bristol-Myers Squibb USD 13.07B 100M 2026-09
Celltrion KRW 1.24T 90B 2026-06
Cspc Pharmaceutical CNY 6.47B 355.1M 2026-03
Deva Holding AS TRY 2.32B 418.58M 2023-09
Dianthus Therapeutics USD 761K 298K 2026-06
Divis Laboratories Ltd INR 36.76B 9.18B 2026-09
Gilead Sciences USD 8.3B 500M 2026-09
Glaxosmithkline GBP 8.89B 1.2B 2026-09
Kangmei Pharma CNY 1.19B 106M 2026-06
Knight Therapeutics CAD 133.11M 11.56M 2025-12
Laboratorios Farma EUR 448.66M 67.82M 2023-12
Medical Developments International AUD 21.57M 12.04M 2025-12
Merck USD 18.1B 1.5B 2026-09
Neuren Pharmaceuticals AUD 42.24M 28.1M 2025-12
Novartis USD 15.03B 1.92B 2026-09
Organigram Holdings CAD 105.78M 45.99M 2026-06
Organon & Co USD 1.57B 10M 2026-09
Pharma Mar EUR 54.2M 4.2M 2026-09
Qiagen NV USD 487.78M 24.66M 2026-09
Sartorius EUR 926.3M 14.5M 2026-09
Sino Biopharmaceutical CNY 19.44B 5.18B 2026-06
Tilray USD 217.51M 74.75M 2025-12
Zealand Pharma A/S 34M 34.92M 2026-03